Showing results (2151-2160 of 2,339) with videos related to

Sort By:
Pageof 234
European Journal of Cancer (Oxford, England : 1990)|August 15, 2015
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trialHenk van den Berg, Michael Paulussen, Gwénaël Le Teuff, et al.
ALTEX|May 8, 2012
A toxicology ontology roadmapBarry Hardy, Gordana Apic, Philip Carthew, et al.
ALTEX|May 8, 2012
Toxicology ontology perspectivesBarry Hardy, Gordana Apic, Philip Carthew, et al.
Chest|October 26, 2017
Clinical Course of Sarcoidosis in World Trade Center-Exposed FirefightersKerry M Hena, Jennifer Yip, Nadia Jaber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2018
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida PanelCornelius J Clancy, Peter G Pappas, Jose Vazquez, et al.
Oncotarget|October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysisMarion Savina, Saskia Litière, Antoine Italiano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumorsJosep Tabernero, Federico Rojo, Emiliano Calvo, et al.
Science (New York, N.Y.)|November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasionRobert D Leone, Liang Zhao, Judson M Englert, et al.
The European Respiratory Journal|August 7, 2025
Pulmonary Sarcoidosis Clinical Trial Endpoints: A Delphi StudyRobert P Baughman, Jan C Grutters, Elyse E Lower, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Pageof 234